AGL 38.60 Increased By ▲ 0.04 (0.1%)
AIRLINK 213.99 Increased By ▲ 6.22 (2.99%)
BOP 10.07 Increased By ▲ 0.01 (0.1%)
CNERGY 6.54 Decreased By ▼ -0.54 (-7.63%)
DCL 9.62 Decreased By ▼ -0.37 (-3.7%)
DFML 40.20 Decreased By ▼ -0.94 (-2.28%)
DGKC 100.01 Decreased By ▼ -3.45 (-3.33%)
FCCL 35.85 Decreased By ▼ -0.50 (-1.38%)
FFBL 89.99 Decreased By ▼ -1.60 (-1.75%)
FFL 13.98 Decreased By ▼ -0.62 (-4.25%)
HUBC 136.40 Decreased By ▼ -3.03 (-2.17%)
HUMNL 13.98 Decreased By ▼ -0.12 (-0.85%)
KEL 5.85 Decreased By ▼ -0.12 (-2.01%)
KOSM 7.38 Decreased By ▼ -0.48 (-6.11%)
MLCF 46.44 Decreased By ▼ -0.84 (-1.78%)
NBP 66.38 Decreased By ▼ -7.38 (-10.01%)
OGDC 220.90 Decreased By ▼ -1.76 (-0.79%)
PAEL 38.45 Increased By ▲ 0.34 (0.89%)
PIBTL 8.93 Decreased By ▼ -0.34 (-3.67%)
PPL 202.48 Decreased By ▼ -3.37 (-1.64%)
PRL 39.55 Decreased By ▼ -0.30 (-0.75%)
PTC 26.20 Decreased By ▼ -0.42 (-1.58%)
SEARL 107.00 Decreased By ▼ -3.24 (-2.94%)
TELE 9.16 Decreased By ▼ -0.07 (-0.76%)
TOMCL 37.00 Decreased By ▼ -1.21 (-3.17%)
TPLP 13.80 Increased By ▲ 0.03 (0.22%)
TREET 25.91 Decreased By ▼ -0.54 (-2.04%)
TRG 59.01 Decreased By ▼ -1.53 (-2.53%)
UNITY 33.20 Decreased By ▼ -0.94 (-2.75%)
WTL 1.75 Decreased By ▼ -0.13 (-6.91%)
BR100 12,078 Decreased By -221.3 (-1.8%)
BR30 37,938 Decreased By -939.7 (-2.42%)
KSE100 113,006 Decreased By -1855 (-1.61%)
KSE30 35,599 Decreased By -597.3 (-1.65%)

KARACHI: The Drug Regulatory Authority of Pakistan (DRAP) has registered’ another locally produced ventilator, ‘Innovent’, in Pakistan, sources said Tuesday.

As per details, the Innovent ventilator, manufactured by Essence Industries Karachi, has successfully completed its clinical trials.

DRAP has officially registered the Innovent ventilator and issued a license to Essence Industries for its local production. In addition to meeting domestic demand, the ventilators will also be exported, contributing to the Pakistan’s economy.

The Innovent ventilator has a shelf life of five years and is specifically designed for use by elderly patients, DRAP sources added.

Talking to a private television channel, DRAP CEO Dr. Asim Rauf said the priority of promoting Made in Pakistan medicines and medical equipment.

“Pakistan’s pharmaceutical industry has entered a new era, and the export of locally produced ventilators will generate significant foreign exchange for the country. These live-saving machines will also serve as a symbol of Pakistan’s global recognition,” Dr. Asim Rauf stated. He further highlighted that the success of Made in Pakistan medical devices reflects the country’s growing technological capabilities and commitment to innovation.

Earlier in 2021, the Drug Regulatory Authority of Pakistan (DRAP) registered an indigenously-developed intensive care unit (ICU) ventilator named “i-LIVE”.

The life-support machine was developed by the Pakistan Atomic Energy Commission (PAEC).

Chief Executive Officer of the DRAP Dr. Asim Rauf said that the i-LIVE ventilator was registered for a five-year period under the DRAP Act 2012 after its thorough technical examination.

Comments

200 characters